Advertisement
Home 2016

Archives

For patients with critical limb ischemia

ACC: Good Outcomes for Endovascular Procedures for CLI

0
Increase in endovascular procedures linked to decrease in in-hospital death, major amputation
A genetic test of homologous recombination genes might help predict outcomes for women diagnosed with ovarian cancer

Gene Panel Test May Help Predict Ovarian Cancer Prognosis

0
Women with mutations in some 'DNA repair' genes may survive much longer, research shows
For patients requiring dual antiplatelet therapy

ACC: PPI Tx Also Beneficial for Those on Low-Dose Aspirin

0
Gastroprotection with PPI therapy reduced primary GI end point in patients on low-dose aspirin
Late parenteral nutrition is superior to early parenteral nutrition for children in the pediatric intensive care unit

Late Parenteral Nutrition Superior in Pediatric ICU

0
Withholding nutrition for one week clinically superior for critically ill children
Severe migraines are associated with an increased risk of complications during pregnancy and childbirth

AAN: Preeclampsia, LBW Up With Severe Migraine While Pregnant

0
Women older than 35 appear most at risk, researchers find
The 21-gene recurrence score (Oncotype DX) seems to accurately identify women with early-stage breast cancer who don't need chemotherapy

Gene Test IDs Breast CA Patients Who May Not Need Chemo

0
Analysis can help women who won't benefit from additional treatment to avoid side effects
For women with early-stage breast cancer

Targeted Radiation Shows Promise in Early Breast Cancer

0
Limited radiotherapy effective after low-risk tumors are removed, but questions remain
Women with diabetes who take insulin appear to have a higher incidence of dense breasts

Insulin Treatment May Up Breast Density in Diabetes Patients

0
Women on insulin might need extra breast cancer screening
Adding core-needle biopsy to other clinical care may help improve outcomes for some patients with renal cell carcinoma

Core-Needle Biopsy Effective in Evaluation of Renal Masses

0
Image-guided testing of tissue from the renal mass may lead to improved treatments, researchers say
The drug combination of lapatinib (Tykerb) and trastuzumab (Herceptin) induces tumor regression or disappearance in 25 percent of human epidermal growth factor receptor 2 (HER2)-positive cancers in 11 days

Lapatinib + Trastuzumab May Rapidly Shrink Breast Tumors

0
Researchers say combo therapy works well for about one in four women with HER2+ breast cancer